Quarterly report pursuant to Section 13 or 15(d)

Acquisition of Emerald Health Therapeutics, Inc. - Pro Forma Adjustments (Details)

v3.22.2.2
Acquisition of Emerald Health Therapeutics, Inc. - Pro Forma Adjustments (Details)
Sep. 30, 2022
USD ($)
Sep. 30, 2022
CAD ($)
Jun. 30, 2022
USD ($)
Mar. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Sep. 30, 2021
USD ($)
Jun. 30, 2021
USD ($)
Mar. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Asset Acquisition [Line Items]                  
Exchange rate 0.73037 0.73037              
Current assets                  
Cash and cash equivalents $ 415,389       $ 8,983,007 $ 11,089,624      
Accounts receivable 0                
Prepaid expenses 708,477       554,217        
Assets held for sale 0                
Total current assets 2,683,285       9,612,097        
Property, plant and equipment, net 86,163       87,710        
Promissory note receivable 0                
Total assets 2,868,821       9,855,088        
Current liabilities                  
Accounts payable - related parties 120,216       2,130        
Accrued payroll liabilities 443,983       344,450        
Other current liabilities 526,818       375,842        
Insurance premium loan payable 30,615       0        
Current liabilities held for sale 0                
Total current liabilities 6,145,575       3,912,222        
Equity [Abstract]                  
Additional paid-in-capital 53,065,217       52,644,221        
Accumulated other comprehensive income 0                
Accumulated deficit (56,846,123)       (47,256,163)        
Total stockholders’ equity (3,284,981)   $ (301,822) $ 2,973,092 5,864,166 $ 8,264,782 $ 2,271,104 $ 2,478,649 $ 450,786
Total liabilities and stockholders’ equity 2,868,821       $ 9,855,088        
Emerald Health Therapeutics, Inc.                  
Current assets                  
Cash and cash equivalents 8,177,488 $ 11,196,364              
Accounts receivable 631,349 864,424              
Prepaid expenses 837,106 1,146,140              
Assets held for sale 9,104,151 12,465,122              
Total current assets 18,750,094 25,672,050              
Property, plant and equipment, net 1,445,309 1,978,872              
Promissory note receivable 350,391 479,745              
Total assets 20,545,794 28,130,667              
Current liabilities                  
Accounts payable and accrued liabilities 927,222 1,269,523              
Accounts payable - related parties 9,024 12,355              
Accrued payroll liabilities 21,303 29,167              
Other current liabilities 1,380,526 1,890,173              
Insurance premium loan payable 185,357 253,785              
Current liabilities held for sale 31,998 43,811              
Total current liabilities 2,555,430 3,498,814              
Equity [Abstract]                  
Additional paid-in-capital 205,511,125 281,379,472              
Accumulated other comprehensive income 83,346 114,115              
Accumulated deficit (187,604,107) (256,861,734)              
Total stockholders’ equity 17,990,364 24,631,853              
Total liabilities and stockholders’ equity $ 20,545,794 $ 28,130,667